CIK 0001850119 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Century Therapeutics, Inc.
Sign in to watch- Ticker
- IPSC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 842040295
- Phone
- 215-981-4000
- Business address
- 25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,212
- in 5 filings
Net −$10,212. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 63 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-02 | Carr Douglas SVP Finance & Operations | Grant or award | +110,000 | 514,874 | ||
| 2026-02-02 | Carr Douglas SVP Finance & Operations | Grant or award · Stock Option (right to buy) | +225,000 | 225,000 | ||
| 2026-01-02 | Cowan Chad Chief Scientific Officer | Shares withheld for taxes | −1,611 | $1.00 | $2K | 1,043,476 |
| 2025-12-22 | Cowan Chad Chief Scientific Officer | Purchase | +58,060 | $0.85 | $49K | 1,045,087 |
| 2025-12-12 | Pfeiffenberger Brent President and CEO | Purchase | +52,000 | $0.58 | $30K | 3,322,990 |
| 2025-12-10 | Pfeiffenberger Brent President and CEO | Shares withheld for taxes | −463 | $0.53 | $244 | 3,270,990 |
| 2025-12-09 | Murphy Martin Patrick Director | Grant or award · Stock Option (right to buy) | +88,000 | 88,000 | ||
| 2025-12-09 | Lee Han Myung Director | Grant or award · Stock Option (right to buy) | +88,000 | 88,000 | ||
| 2025-12-08 | Russotti Gregory See Remarks | Sale | −526 | $0.53 | $280 | 390,982 |
| 2025-12-08 | Carr Douglas SVP Finance & Operations | Sale | −257 | $0.53 | $137 | 404,874 |
| 2025-11-20 | Cowan Chad Chief Scientific Officer | Sale | −5,462 | $0.50 | $3K | 987,027 |
| 2025-11-19 | Pfeiffenberger Brent President and CEO | Purchase | +35,000 | $0.50 | $17K | 3,271,453 |
| 2025-11-17 | Pfeiffenberger Brent President and CEO | Sale | −32,456 | $0.45 | $15K | 3,236,453 |
| 2025-11-03 | Carr Douglas SVP Finance & Operations | Sale | −292 | $0.59 | $171 | 405,131 |
| 2025-09-18 | Cowan Chad Chief Scientific Officer | Grant or award | +762,543 | 992,489 | ||
| 2025-09-08 | Carr Douglas SVP Finance & Operations | Sale | −263 | $0.50 | $132 | 405,423 |
| 2025-09-08 | Pfeiffenberger Brent President and CEO | Sale | −488 | $0.50 | $244 | 3,268,909 |
| 2025-09-08 | Russotti Gregory See Remarks | Sale | −539 | $0.50 | $270 | 391,508 |
| 2025-08-14 | Pfeiffenberger Brent President and CEO | Grant or award | +1,587,614 | 3,269,397 | ||
| 2025-08-04 | Carr Douglas SVP Finance & Operations | Sale | −296 | $0.53 | $158 | 405,686 |
Page 3 of 6 · 118 trades